Demant A/S updated earnings guidance for 2023. For the year the company now expects the Organic growth of 11% to 14% (previously 6% to 10%). EBIT from DKK 4,000 to 4,400 million (previously DKK 3,800 to 4,200 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
339 DKK | +3.80% | +3.99% | +14.53% |
05-29 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
05-21 | Denmark's Demant Completes Sale of Cochlear Implants Business | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.53% | 10.23B | |
-15.41% | 20.21B | |
+8.68% | 14.09B | |
-22.57% | 1.99B | |
-2.37% | 1.6B | |
+6.10% | 1.31B | |
-0.23% | 535M | |
0.00% | 399M | |
+72.36% | 191M | |
+24.42% | 100M |
- Stock Market
- Equities
- DEMANT Stock
- News Demant A/S
- Demant A/S Updates Earnings Guidance for 2023